Sandbox Reserved 324: Difference between revisions
No edit summary |
No edit summary |
||
| Line 8: | Line 8: | ||
{{STRUCTURE_1q8k| PDB=1q8k | SCENE= }} | {{STRUCTURE_1q8k| PDB=1q8k | SCENE= }} | ||
=Structure= | =Structure= | ||
The human eIF2 structure was determined by NMR spectroscopy<ref name="1q8k"/>. The human eIF2 structure is a small structure made of two domains<ref name="1q8k"/>. These two domains have a unique characteristic in that they are mobile relative to the other domain<ref name="1q8k"/>. The N terminal domain (NTD) of the structure, of eIF2 structures, was discovered in previous years<ref name="dhal">doi:10.1016<ref/>, where the C-terminal domain (CTD) for the human eIF2 was undetermined until the whole structure was discovered. The CTD contains a αβ-fold, which remarkably has a similar appearance to the CTD of eEF1Bα, a translation elongation factor, even though there is no sequence homology between the two<ref name="1q8k"/>. | The human eIF2 structure was determined by NMR spectroscopy<ref name="1q8k"/>. The human eIF2 structure is a small structure made of two domains<ref name="1q8k"/>. These two domains have a unique characteristic in that they are mobile relative to the other domain<ref name="1q8k"/>. The N terminal domain (NTD) of the structure, of eIF2 structures, was discovered in previous years<ref name="dhal">doi:10.1016<ref/>, where the C-terminal domain (CTD) for the human eIF2 was undetermined until the whole structure was discovered. The CTD contains a αβ-fold, which remarkably has a similar appearance to the CTD of eEF1Bα, a translation elongation factor, even though there is no sequence homology between the two<ref name="1q8k"/>. | ||